Long noncoding RNA ANRIL is activated by hypoxia-inducible factor-1α and promotes osteosarcoma cell invasion and suppresses cell apoptosis upon hypoxia.
BACKGROUND
Osteosarcoma is the most common malignancy of bone. Intratumoral hypoxia occurs in many solid tumors, where it is associated with the development of aggressive phenotype. ANRIL has been shown to be a long noncoding RNA that facilitates the progression of a number of malignancies. Yet, few studies have explored the expression pattern of ANRIL in osteosarcoma and the effect of hypoxia on ANRIL.


METHODS
We evaluated the expression levels of ANRIL in osteosarcoma tissues, adjacent normal tissues and cells with quantitative real-time polymerase chain reaction. Multiple approaches including luciferase reporter assay with nucleotide substitutions, chromatin immunoprecipitation assay and electrophoretic mobility shift assay were used to confirm the direct binding of HIF-1α to the ANRIL promoter region. SiRNA-based knockdown and other molecular biology techniques were employed to measure the effect of HIF-1α on the expression of ANRIL.


RESULTS
We found that the expression of ANRIL was upregulated in 15 pairs of osteosarcoma compared with adjacent normal tissues. We found that hypoxia is sufficient to upregulate ANRIL expression in osteosarcoma cells (MNNG and U2OS). HIF-1α directly binds to the putative hypoxia response element in the upstream region of ANRIL. What's more, siRNA and small molecular inhibitors-mediated HIF-1α suppression attenuated ANRIL upregulation under hypoxic conditions. Upon hypoxia, ANRIL promoted cancer cell invasion and suppressed cell apoptosis.


CONCLUSIONS
Taken together, these data suggest that HIF-1α may contribute to the upregulation of ANRIL in osteosarcoma under hypoxic conditions. ANRIL is involved in hypoxia-induced aggressive phenotype in osteosarcoma.
Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No 100 Hanning Road, Shanghai, 200080 People's Republic of China.
Xiaokang
X
Wei
Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No 100 Hanning Road, Shanghai, 200080 People's Republic of China.
Chuanshun
C
Wang
Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No 100 Hanning Road, Shanghai, 200080 People's Republic of China.
Chunhui
C
Ma
Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No 100 Hanning Road, Shanghai, 200080 People's Republic of China.
Wei
W
Sun
Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No 100 Hanning Road, Shanghai, 200080 People's Republic of China.
Haoqing
H
Li
Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No 100 Hanning Road, Shanghai, 200080 People's Republic of China.
Zhendong
Z
Cai
ANRIL; HIF-1α; Hypoxia; Long noncoding RNA; Osteosarcoma
Oncotarget. 2014 Apr 30;5(8):2276-92
24810364
Cell Signal. 2013 May;25(5):1086-95
23416462
Cancer Cell. 2014 May 12;25(5):666-81
24768205
Ann Oncol. 2014 Sep;25 Suppl 3:iii113-23
25210081
Cell Death Dis. 2015 Jan 08;6:e1583
25569100
J Cell Sci. 2014 Apr 1;127(Pt 7):1585-94
24463816
J Clin Oncol. 2015 Sep 20;33(27):3029-35
26304877
Cancer Cell. 2015 May 11;27(5):682-97
25965573
Cancer Epidemiol. 2015 Aug;39(4):593-9
26002013
Cancer Res. 2015 Nov 15;75(22):4839-51
26424695
Mol Cell. 2013 Mar 28;49(6):1083-96
23395002
Pathology. 2014 Feb;46(2):95-104
24378391
Cell Death Dis. 2014 Jun 26;5:e1301
24967963
Genes Dev. 1998 Jan 15;12(2):149-62
9436976
Mol Cell. 2014 Jan 9;53(1):88-100
24316222
Nat Rev Cancer. 2011 Jun;11(6):393-410
21606941
Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):E5429-38
25453096
Mol Cell. 2010 Jun 11;38(5):662-74
20541999
Mol Cancer Ther. 2015 Jan;14(1):268-77
25504755
J Exp Clin Cancer Res. 2015 Feb 28;34:22
25884381
Oncogene. 2015 Aug 20;34(34):4482-90
25417700
FEBS Lett. 2014 Sep 17;588(18):3333-9
25080009
J Cell Biochem. 2009 Aug 15;107(6):1053-62
19479945